Skip to main content

Table 1 Different definitions of metabolic syndrome

From: Does the impact of metabolic syndrome on cardiovascular events vary by using different definitions?

 

WHO

EGIR

NCEP ATP III

AHA

IDF

JIS

Definitions

insulin resistance together with two or more of the following:

Insulin resistance or impaired fasting glucose (IFG) plus two of the following:

Three or more of the following five risk factors:

Three or more of the following five risk factors:

Central obesity plus 2 other features

Three or more of the following five risk factors:

Fasting plasma glucose

__

≥ 6.1 mmol/l (110 mg/dl) but non-diabetic

≥ 6.1 mmol/l (110 mg/dl)

≥ 5.6 mmol/l (100 mg/dl)

≥ 5.6 mmol/l (100 mg/dl) or diagnosed type 2 diabetes

≥ 5.6 mmol/l (100 mg/dl)

Central obesity

Men: waist-hip ratio > 0.90

Men: waist circumference ≥ 94 cm

Men: waist circumference > 102 cm

Men: waist circumference > 102 cm

Men: waist circumference ≥ 94 cm,

Ethnic cut point for waist circumferencea

Women: waist-hip ratio > 0.85 and/or BMI > 30 kg/m2

Women: waist circumference ≥ 80 cm

Women: waist circumference > 88 cm

Women: waist circumference > 88 cm

Women: waist circumference ≥ 80 cma or BMI > 30 kg/m2

Blood pressure

≥ 140/90 mmHg

≥ 140/90 mmHg or treatment

≥ 130/85 mmHg

≥130/85 mmHg

≥ 130/85 mmHg or treatment

≥ 130/85 mmHg

Triglycerides

≥ 1.7 mmol/l (150 mg/dl)

> 2.0 mmol/l (178 mg/dl)

≥1.7 mmol/l (150 mg/dl) or treatment

≥1.7 mmol/l (150 mg/dl) or treatment

≥1.7 mmol/l (150 mg/dl) or treatment

≥ 1.7 mmol/l (150 mg/dl) or treatment

HDL-cholesterol

Men: < 0.9 mmol/l (35 mg/dl)

< 1.0 mmol/l (39 mg/dl) or treatment

Men: < 1.03 mmol/l (40 mg/dl)

Men: < 1.03 mmol/l (40 mg/dl)

Men: <1.0 mmol/l (39 mg/dl)

Men: < 1.03 mmol/l (40 mg/dl)

Women: < 1.0 mmol/l (39 mg/ dl)

Women: < 1.29 mmol/l (50 mg/ dl)

Women: < 1.29 mmol/l (50 mg/dl)

Women: <1.3 mmol/l (40 mg/dl) or treatment

Women: < 1.29 mmol/l (50 mg/dl)

  1. abased on Iranian cut off point, Waist Circumference ≥ 95 for both sexes